Abstract
A prospective study of 120 patients newly diagnosed as having Hodgkin's disease and non-Hodgkin's lymphoma was conducted to determine the nature, extent, and timing of the psychiatric and social morbidity associated with the diagnosis and treatment. Patients were interviewed at diagnosis and two, six, and 12 months later by trained interviewers using standardised questionnaires. Psychiatric morbidity was greatest in the three months before treatment, but new episodes of anxiety and depression developed throughout the year of follow up. Altogether 39 patients suffered a depressive illness or anxiety state, or both, and a further 37 experienced borderline anxiety or depression, or both, during the 15 months of assessment. The most common adverse effects of treatment were hair loss, nausea, vomiting, sore mouth, and changes in perception of taste. Toxicity of treatment was associated with psychiatric morbidity. Conditioned responses to chemotherapy were experienced by 32 patients. Social morbidity was low, although difficulties in returning to work and to previous levels of leisure activity were noted. Although most patients were no longer receiving treatment and were free of disease at the one year follow up, 51 patients continued to complain of loss of energy, 24 of loss of libido, 38 of tiredness, 23 of irritability, 18 of poor concentration, and 23 of memory impairment. These results confirm our retrospective study and suggest that a high price is paid for long term survival by a substantial proportion of patients receiving treatment for Hodgkin's disease and non-Hodgkin's lymphoma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chapman R. M., Sutcliffe S. B., Rees L. H., Edwards C. R., Malpas J. S. Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet. 1979 Feb 10;1(8111):285–289. doi: 10.1016/s0140-6736(79)90701-3. [DOI] [PubMed] [Google Scholar]
- Clare A. W., Cairns V. E. Design, development and use of a standardized interview to assess social maladjustment and dysfunction in community studies. Psychol Med. 1978 Nov;8(4):589–604. doi: 10.1017/s0033291700018808. [DOI] [PubMed] [Google Scholar]
- Fobair P., Hoppe R. T., Bloom J., Cox R., Varghese A., Spiegel D. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol. 1986 May;4(5):805–814. doi: 10.1200/JCO.1986.4.5.805. [DOI] [PubMed] [Google Scholar]
- Lloyd G. G., Parker A. C., Ludlam C. A., McGuire R. J. Emotional impact of diagnosis and early treatment of lymphomas. J Psychosom Res. 1984;28(2):157–162. doi: 10.1016/0022-3999(84)90009-6. [DOI] [PubMed] [Google Scholar]
- Maguire G. P., Lee E. G., Bevington D. J., Küchemann C. S., Crabtree R. J., Cornell C. E. Psychiatric problems in the first year after mastectomy. Br Med J. 1978 Apr 15;1(6118):963–965. doi: 10.1136/bmj.1.6118.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morrow G. R. Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients. J Natl Cancer Inst. 1982 Apr;68(4):585–588. [PubMed] [Google Scholar]
- Packer R. J., Zimmerman R. A., Bilaniuk L. T. Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer. 1986 Aug 1;58(3):635–640. doi: 10.1002/1097-0142(19860801)58:3<635::aid-cncr2820580307>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
- Redd W. H., Andrykowski M. A. Behavioral intervention in cancer treatment: controlling aversion reactions to chemotherapy. J Consult Clin Psychol. 1982 Dec;50(6):1018–1029. doi: 10.1037//0022-006x.50.6.1018. [DOI] [PubMed] [Google Scholar]
- Schilsky R. L., Lewis B. J., Sherins R. J., Young R. C. Gonadal dysfunction in patients receiving chemotherapy for cancer. Ann Intern Med. 1980 Jul;93(1):109–114. doi: 10.7326/0003-4819-93-1-109. [DOI] [PubMed] [Google Scholar]